Clincosm LogoSign in Get a demo

Non Alcoholic Fatty Liver Disease

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

UDFF Performance Evaluation ((Ultrason Derived Fat Fraction)

Recruiting
  • Non Alcoholic Fatty Liver Disease
  • UDFF
  • Angers, France
    Angers university hospital
Oct 6, 2023

Non Alcoholic Fatty Liver Disease Trial in Kopavogur, Kópavogur (A digital care solution for patients with NAFLD)

Recruiting
  • Non Alcoholic Fatty Liver Disease
  • A digital care solution for patients with NAFLD
  • Kopavogur, Iceland
  • +1 more
Jun 21, 2022

Non Alcoholic Fatty Liver Disease Trial in Athens (Mastiha, Placebo)

Completed
  • Non Alcoholic Fatty Liver Disease
  • Mastiha
  • Placebo
  • Athens, Attica, Greece
    Harokopio University
Apr 6, 2022

Diabetes Type 2, Non Alcoholic Fatty Liver Disease, Obesity Trial in Ann Arbor (Amlexanox)

Suspended
  • Diabetes Mellitus Type 2
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan
Jan 10, 2022

Non Alcoholic Fatty Liver Disease, Type2 Diabetes Trial in Gurgaon (Dulaglutide)

Completed
  • Non Alcoholic Fatty Liver Disease
  • Type2 Diabetes Mellitus
  • Gurgaon, Haryana, India
    Division Of Endocrinology & Diabetes, Medanta The Medicity
Feb 19, 2020

Non Alcoholic Fatty Liver Disease Trial in Cairo (Niacinamide Oral Tablet, Antidiabetic)

Completed
  • Non Alcoholic Fatty Liver Disease
  • Cairo, Egypt
    AlZahraa hospital
Jan 18, 2020

Non Alcoholic Fatty Liver Disease Trial in Gurgaon (Empagliflozin)

Completed
  • Non Alcoholic Fatty Liver Disease
  • Gurgaon, Haryana, India
    Division Of Endocrinology , Medanta The Medicity Sec 38
Aug 13, 2019

Non Alcoholic Fatty Liver Disease, Lifestyle, Diet Modification Trial in Brescia (Mediterranean Style)

Completed
  • Non Alcoholic Fatty Liver Disease
  • +2 more
  • Mediterranean Style
  • Brescia, Italy
    ASST Spedali Civili Brescia
May 22, 2019

Non Alcoholic Fatty Liver Disease Trial in Mexico City (Electronic detailed information, NAFLD Score, Transient elastography)

Completed
  • Non Alcoholic Fatty Liver Disease
  • Electronic detailed information
  • +2 more
  • Mexico City, DF, Mexico
    Medica Sur Clinic & Foundation
Aug 8, 2018

Non Alcoholic Fatty Liver Disease Trial in New Haven (Continuous positive airway pressure (CPAP).)

Terminated
Has Results
  • Non Alcoholic Fatty Liver Disease
  • Continuous positive airway pressure (CPAP).
  • New Haven, Connecticut
    Yale University
Jun 5, 2018

"Preventing Cardiovascular Ischemic Events and Arresting Their

Unknown status
  • Type2 Diabetes Mellitus
  • +6 more
    • Barcelona, Spain
      Hospital Universitario Valle de Hebron
    Jan 19, 2018

    Genetics of Fatty Liver Disease in Children

    Completed
    • Non Alcoholic Fatty Liver Disease
    • ogtt
    • +4 more
    • New Haven, Connecticut
      Yale University
    Dec 6, 2017

    Non Alcoholic Fatty Liver Disease Trial in Nice (Evaluation of the staging of fibrosis liver, Determine the expression level of

    Completed
    • Non Alcoholic Fatty Liver Disease
    • Evaluation of the staging of fibrosis liver
    • +2 more
    • Nice, France
      Service d'Hépato-Gastroentérologie - Hôpital de l'Archet
    Oct 3, 2017

    Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or

    Completed
    • Non Alcoholic Fatty Liver Disease
    • plasma pentraxin-3
    • (no location specified)
    Sep 6, 2017

    Non Alcoholic Fatty Liver Disease, Steatohepatitis, Hypertriglyceridemia Trial in New Haven (Omega diet)

    Completed
    • Non Alcoholic Fatty Liver Disease
    • +3 more
    • Omega diet
    • New Haven, Connecticut
      Yale School of Medicine
    Apr 26, 2017

    Non Alcoholic Fatty Liver Disease Trial in Ramat Gan (atorvastatin, lifestyle counseling)

    Withdrawn
    • Non Alcoholic Fatty Liver Disease
    • Ramat Gan, Israel
      Sheba Medical Center
    Apr 25, 2017

    Non Alcoholic Fatty Liver Disease, Obstructive Sleep Apnea Trial in Baltimore (CPAP (ResMed S9 autoset CPAP))

    Completed
    Has Results
    • Non Alcoholic Fatty Liver Disease
    • Obstructive Sleep Apnea
    • CPAP (ResMed S9 autoset CPAP)
    • Baltimore, Maryland
      Johns Hopkins University
    Nov 1, 2016

    Non Alcoholic Fatty Liver Disease Trial in Columbia (Weight loss, Exercise)

    Completed
    • Non Alcoholic Fatty Liver Disease
    • Weight loss
    • Exercise
    • Columbia, Missouri
      University Hospital
    Oct 3, 2016

    Non Alcoholic Fatty Liver Disease Trial in Vienna (Px-104)

    Completed
    • Non Alcoholic Fatty Liver Disease
    • Vienna, Austria
      Division of Gastroenterology and Hepatology, Department of Inter
    Sep 28, 2016

    Non Alcoholic Fatty Liver Disease Trial in Worldwide (SAMe 1000 mg, SAMe 1500 mg, SAMe 2000 mg)

    Completed
    Has Results
    • Non Alcoholic Fatty Liver Disease
    • SAMe 1000 mg
    • +2 more
    • Amiens, France
    • +31 more
    Jan 22, 2016

    Non Alcoholic Fatty Liver Disease Trial in Guildford, Liverpool, London (Unsupervised exercise training, Supervised exercise

    Unknown status
    • Non Alcoholic Fatty Liver Disease
    • Unsupervised exercise training
    • Supervised exercise training
    • Guildford, Surrey, United Kingdom
    • +6 more
    Sep 16, 2014

    Pathophysiological Implications of Incretin Hormones in Liver

    Completed
    • Non Alcoholic Fatty Liver Disease
    • +2 more
    • OGTT
    • IIGI
    • Hellerup, Denmark
      Diabetes Research Division, Gentofte University Hospital, Niels
    Jul 9, 2014

    Non Alcoholic Fatty Liver Disease Trial in Tabriz (ß- glucan, Maltodextrin)

    Unknown status
    • Non Alcoholic Fatty Liver Disease
    • β- glucan
    • Maltodextrin
    • Tabriz, Iran, Islamic Republic of
      Shekh-al- rais Clinic
    Jun 27, 2014

    Metabolic Syndrome, Non Alcoholic Fatty Liver Disease, Insulin Resistance Trial in Rome (glucomannan, lifestyle intervention)

    Completed
    • Metabolic Syndrome
    • +2 more
    • glucomannan
    • lifestyle intervention
    • Rome, Italy
      Bambino Gesù Children's Hospital and Research Institute
    Apr 1, 2014

    Non Alcoholic Fatty Liver Disease Trial in Edinburgh (Omacor, lactose tablet)

    Completed
    • Non Alcoholic Fatty Liver Disease
    • Edinburgh, Lothian, United Kingdom
      Royal Infirmary of Edinburgh
    Jan 22, 2014